George S. Karagiannis is an assistant professor in the Department of Microbiology and Immunology (M&I) at the Albert Einstein College of Medicine, Bronx, NY, USA. He is also affiliated with the Albert Einstein Cancer Center (AECC). He holds a Ph.D. in Cancer Biology from University of Toronto, Canada, and a degree in Veterinary Medicine (D.V.M.) from Aristotle University of Thessaloniki, Thessaloniki, Greece. His scientific contributions (>45 peer-reviewed, primary research articles and review articles) have appeared in highly-esteemed journals and specialized society journals in the fields of cancer biology, molecular oncology, cancer proteomics, and translational medicine. His most prominent publications have appeared in Science Translational Medicine, Molecular and Cellular Proteomics, The Journal of Biological Chemistry, Molecular Cancer Therapeutics, Molecular Cancer Research, and Molecular Oncology. The most prestigious research-related award he has received to-date is the NCI Pathway to Independence Award (K99/R00). Dr. Karagiannis and his creative team currently investigate the effects of chemotherapy on the primary tumor microenvironment, as well as chemotherapy-driven immunotoxicity on primary and secondary lymphoid organs.